Bausch Health shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY26 sales guidance above estimates. Also, the company announced a $50 million buyback plan.

*Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of tickrs and tickrs cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions.